Modifiable risk factors for CAD
Non-modifiable risk factors for CAD
- Age Men >45 Women >55 - Gender - Family Hx - Personality type - Menopausal status
goals of therapy for chronic stable angina
Two antiplatelet therapies for chronic stable angina list
ASA
Clopidogrel
Chronic stable angina ASA dose
75 - 325 mg daily
Chronic stable angina ASA measures to decrease GI bleeding risk
81 mg ASA + PPI
Clopidogrel dose for chronic stable angina
75 mg daily
When use dual ASA clopidogrel tx with chronic stable angina
only if have had recent ACS or PCI/stent placement
MoA of nitrates, how it relieves/prevents ischemic chest pain
3 determinants of myocardial O2 demand
Preload def
Afterload def
pressure resistance left ventricle must overcome to circulate blood
dosing instructions (dose and frequency) for nitroglycerin for secondary prevention of chest pain in chronic stable angina
0.3-0.6 mg (0.4 is most common) every 5 minutes up to 3 doses
Counseling points for correct use of SL nitroglycerine
ADR ASA
bleeding
ADR Clopidogrel
- neutropenia
ADR Nitroglycerine
ADR Beta Blockers
ADR Calcium Channel Blockers
ADR Nitrates
appropriate dosing regimen for metoprolol tartrate (Lopressor) for the treatment of chronic stable angina
50-100 mg BID
MoA BB to relieve or prevent ischemic chest pain
Contraindications for Beta-blocker in tx of chronic stable angina
Contraindications for nitrates in tx of chronic stable angina
Concurrent use with phosphodiesterase-5 (Viagra, Cialis, etc.)